A hydroxymethylglutaryl coenzyme a reductase inhibitor improves endothelial function within 7-days in patients with chronic hemodialysis

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 21-26

  Kishimoto, Noriaki ^b   Hayashi, Toshio ^a   Sakuma, Ichiro ^c   Kano Hayashi, Hatsuyo ^a   Tsunekawa, Taku ^a   Osawa, Masako ^a   Ina, Kouichiro ^a   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Sapporo General Hospital   (Japan)

Author keywords

Cardiovascular disease; Flow mediated dilatation; Hemodialysis; Nitric oxide; Statin

Indexed keywords

8 ISOPROSTANE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; NITRATE; NITRITE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; FEMALE; HEMODIALYSIS; HUMAN; LOW DRUG DOSE; MALE; MORBIDITY; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; DRUG MECHANISM; ENDOTHELIUM; HUMAN CELL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; VASODILATION;

EID: 78049464150     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.023     Document Type: Article

References (39)

1. KAREN Study Group M. Osawa, K. Kato, K. Itai, T. Onoda, and A. Okayama Cardiovascular risk factors in hemodialysis patients: results from baseline data of kaleidoscopic approaches to patients with end-stage renal disease study J Epidemiol 15 2005 96 105
2. J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301 1307
3. Scandinavian Simvastatin Study Group Randomized trial of cholesterol lowering therapy in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
4. T. Tsunekawa, T. Hayashi, H. Kano, D. Sumi, K. Egashira, and A. Iguchi Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3-days Circulation 104 2001 376 379
5. U. Laufs, V. La Fata, and J.K. Liao Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
6. H. Kano, T. Hayashi, D. Sumi, and A. Iguchi A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: possible relevance of up-regulation of endothelial NO synthase mRNA Biochem Biophys Res Commun 259 1999 414 419
7. M. Igel, T. Sudhop, and K. von Bergmann Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins) Eur J Clin Pharmacol 57 2001 357 364
8. D.S. Celermajer, K.E. Sorensen, and V.M. Gooch Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
9. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Vol 1. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; DHEW Publication 1974: 75-628.
10. T. Hayashi, T. Esaki, D. Sumi, N.K. Thakur, and A. Iguchi Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia-the possible role of peroxynitrite Atherosclerosis 147 1999 349 367
11. H. Itabe, E. Takeshima, and H. Iwasaki A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides J Biol Chem 269 1994 15274 15279
12. H. Kohno, N. Sueshige, and K. Oguri Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody Clin Biochem 33 2000 243 253
13. T. Teramoto, J. Sasaki, and H. Ueshima Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese J Atheroscler Thromb 14 2007 45 50
14. N.J. Stone, S. Bilek, and S. Rosenbaum Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options Am J Cardiol 96 2005 53E 59E
15. Y. Kureishi, Z. Luo, and K. Walsh The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nat Med 6 2000 1004 1010
16. T. Tagawa, T. Imaizumi, K. Egashira, and A. Takeshita Role of nitric oxide in reactive hyperemia in human forearm vessels Circulation 90 1994 2285 2290
17. P. Clarkson, D.S. Celemajer, and A.J. Powe Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease Circulation 96 1997 3378 3383
18. D.V. Barreto, F.C. Barreto, A.B. Carvalho, L. Cuppari, M. Cendoroglo, and S.A. Draibe Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors Kidney Int 67 2005 1576 1582
19. S. Agewall, L. Henareh, and K. Kublickiene Endothelial function in conduit and resistance arteries in men with coronary disease Atherosclerosis 184 2006 130 136
20. T. Neunteufl, and G. Maurer Noninvasive ultrasound techniques for the assessment of atherosclerosis in coronary artery disease Circ J 67 2003 177 186
21. Y. Liu, J. Coresh, and J.A. Eustace Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition JAMA 291 2004 451 459
22. C. Wanner, V. Krane, and W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248
23. G.F.M. Strippoli, S.D. Navaneethan, and D.W. Johnson Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials BMJ 7645 2008 645 651
24. G. Dogra, A. Irish, D. Chan, and G. Watts A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD Am J Kidney Dis 49 2007 776 785
25. L.S. Jeffs, F. Skilton, J. Nitschke, K.M. Bannister, and R.J. Faull Effect of pravastatin on markers of endothelial activation in dialysis patients Nephrology (Carlton) 12 2007 234 238
26. J.W. Olin Atherosclerotic renal artery disease Cardiol Clin 20 2002 547 562
27. S. Blankenberg, S. Barbaux, and L. Tiret Adhesion molecules and atherosclerosis Atherosclerosis 170 2003 191 203
28. D. Tousoulis, C. Antoniades, E. Bosinakou, M. Kotsopoulou, C. Pitsavos, and C. Vlachopoulos Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure Atherosclerosis 178 2005 359 363
29. H. Tanriverdi, H. Evrengul, O. Kuru, S. Tanriverdi, D. Seleci, and Y. Enli Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries Circ J 70 2006 593 599
30. G. O'Driscoll, D. Green, and R.R. Taylor Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1-month Circulation 95 1997 1126 1131
31. G.K. Dogra, G.F. Watts, D.C. Chan, and K. Stanton Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria Diabet Med 22 2005 239 242
32. J.M. Cross, A. Donald, P.J. Vallance, J.E. Deanfield, R.G. Woolfson, and R.J. MacAllister Dialysis improves endothelial function in humans Nephrol Dial Transplant 16 2001 1823 1829
33. A.H. Wagner, T. Kohler, and U. Ruckschloss mprovement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler Thromb Vasc Biol 20 2000 61 69
34. N.K. Thakur, T. Hayashi, M. Jayachandran, H. Kano, and A. Iguchi Stabilization of atherosclerosis by a HMG-CoA reductase inhibitor-effects of increasing basal NO and decreasing superoxide Am J Physiol 281 2001 H75 H83
35. - through endothelial GTPCH1 and NADPH oxidase Life Sci 75 2004 3185 3194
36. A. Fukatsu, T. Hayashi, and A. Miyazaki-Akita Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention from nitric oxide donor-induced endothelial cell abnormalities Am J Physiol Heart Circ Physiol 293 2007 H790 H797
37. A. Miyazaki-Akita, T. Hayashi, and Q.F. Ding 17beta-estradiol antagonizes the down-regulation of endothelial nitric-oxide synthase and GTP cyclohydrolase I by high glucose: relevance to postmenopausal diabetic cardiovascular disease J Pharmacol Exp Ther 320 2007 591 598
38. T. Hayashi, P.A. Juliet, and H. Matsui-Hirai l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits Proc Natl Acad Sci U S A 102 2005 13681 13686
39. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150